Drug
Venglustat clinical trials
Also written GZ/SAR402671 and Genz-682452.
- studies test it
- 14
- open now
- 0
- in phase 3
- 4
- first study started
- 2012
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
14 studies that test it; most in 2020 (3)
| Year | Studies |
|---|---|
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 3 |
| 2022 | 3 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 4
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses venglustat is read from its arms, and is right about nine times in ten.
Testing it · 14
- A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry DiseaseActive, not recruitingPhase 3SanofiNCT05206773Written as Venglustat (GZ402671)
- Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3Active, not recruitingPhase 3SanofiNCT05222906Written as Venglustat
- Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy ExtensionActive, not recruitingPhase 2Genzyme, a Sanofi CompanyNCT02843035Written as venglustat (GZ402671)
- A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry DiseaseActive, not recruitingPhase 3SanofiNCT05280548Written as Venglustat (GZ402671)
- Excretion Balance, Pharmacokinetics, and Metabolism Following of [14C]-Venglustat Administration in Healthy Male SubjectsCompletedPhase 1Genzyme, a Sanofi CompanyNCT05238714Written as venglustat
- A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic FunctionCompletedPhase 1SanofiNCT05718258Written as Venglustat (GZ402671)
- A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male ParticipantsCompletedPhase 1Genzyme, a Sanofi CompanyNCT06421714Written as Venglustat
- A Study of the Safety, Tolerability, and Bioavailability of Orally Administered Venglustat in Healthy Adult ParticipantsCompletedPhase 1SanofiNCT06418620Written as Venglustat
- A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult ParticipantsCompletedPhase 1SanofiNCT06418607Written as Venglustat
- A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD PatientsTerminatedPhase 2/3Genzyme, a Sanofi CompanyNCT03523728Written as Venglustat
- Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry DiseaseCompletedPhase 2Genzyme, a Sanofi CompanyNCT02489344Written as GZ/SAR402671
- Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry DiseaseCompletedPhase 2Genzyme, a Sanofi CompanyNCT02228460Written as GZ/SAR402671
- A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Genz-682452 in Healthy VolunteersCompletedPhase 1Genzyme, a Sanofi CompanyNCT01710826Written as Genz-682452
- Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy MenCompletedPhase 1Genzyme, a Sanofi CompanyNCT01674036Written as Genz-682452
Codes
What other systems call venglustat · ClinicalTrials.gg INT000468
- MeSH (NLM) C000608118venglustatConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) BLP1XA3FZAVENGLUSTATConfirmed FDA, NLM, Wikidata
- Wikidata Q27274745venglustatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152852VenglustatOne source FDA
- DrugBank DB14966One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000608118 | venglustat | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | BLP1XA3FZA | VENGLUSTAT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27274745 | venglustat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152852 | Venglustat | One source FDA |
| DrugBank | DB14966 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.